Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
Marcén R, Morales JM, del Castillo D, Campistol JM, Serón D, Valdés F, Anaya F, Andrés A, Arias M, Bustamante J, Capdevila L, Escuin F, Gil-Vernet S, Gonzalez-Molina M, Lampreave I, Oppenheimer F, Pallardó L; Spanish Renal Forum. Marcén R, et al. Among authors: capdevila l. Transplant Proc. 2006 Dec;38(10):3530-2. doi: 10.1016/j.transproceed.2006.10.033. Transplant Proc. 2006. PMID: 17175323
Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
Pascual J, Segoloni G, Gonzalez Molina M, del Castillo D, Capdevila L, Arias M, Garcia J, Ortuño J; Spanish-Italian Tacrolimus Study Group. Pascual J, et al. Among authors: capdevila l. Transplant Proc. 2003 Aug;35(5):1701-3. doi: 10.1016/s0041-1345(03)00608-0. Transplant Proc. 2003. PMID: 12962764 Clinical Trial.
Renal function in patients with cadaveric kidney transplants treated with tacrolimus or cyclosporine.
Gonzalez Molina M, Morales JM, Marcen R, Campistol JM, Oppenheimer F, Serón D, Gil-Vernet S, Capdevila L, Andrés A, Lampreave I, Del Castillo D, Cabello M, Burgos D, Valdés F, Anaya F, Escuín F, Arias M, Pallardó L, Bustamante J. Gonzalez Molina M, et al. Among authors: capdevila l. Transplant Proc. 2007 Sep;39(7):2167-9. doi: 10.1016/j.transproceed.2007.07.043. Transplant Proc. 2007. PMID: 17889126
Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study.
González Molina M, Serón D, García del Moral R, Carrera M, Sola E, Gómez Ullate P, Capdevila L, Gentil MA; Spanish Mycophenolate Mofetil and Chronic Graft Nephropathy Study Group. González Molina M, et al. Among authors: capdevila l. Transplant Proc. 2002 Feb;34(1):335-7. doi: 10.1016/s0041-1345(01)02788-9. Transplant Proc. 2002. PMID: 11959313 Clinical Trial. No abstract available.
Safety and efficacy of delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors over 55 years of age.
Gentil MA, Osuna A, Capdevila L, Rodriguez-Algarra G, Cantarell C, Pereira P, González-Molina M; Spanish Kidney Transplant of Elderly Donor Study Group. Gentil MA, et al. Among authors: capdevila l. Transplant Proc. 2003 Aug;35(5):1706-8. doi: 10.1016/s0041-1345(03)00609-2. Transplant Proc. 2003. PMID: 12962766
Two doses of daclizumab with delayed introduction of low-dose tacrolimus in elderly recipients of cadaveric renal transplants from donors >55 years of age.
Osuna A, Gentil MA, Capdevila L, Cantarell C, Mazuecos A, Pereira P, Rodríguez-Algarra G, González-Molina M; Spanish Kidney Transplant of Elderly Donor Study Group. Osuna A, et al. Among authors: capdevila l. Transplant Proc. 2005 Apr;37(3):1438-40. doi: 10.1016/j.transproceed.2005.02.039. Transplant Proc. 2005. PMID: 15866630 Clinical Trial.
Gastrointestinal complications in renal transplant recipients: MITOS study.
Gil-Vernet S, Amado A, Ortega F, Alarcón A, Bernal G, Capdevila L, Crespo JF, Cruzado JM, De Bonis E, Esforzado N, Fernandez AM, Franco A, Hortal L, Jiménez C; MITOS Study Group. Gil-Vernet S, et al. Among authors: capdevila l. Transplant Proc. 2007 Sep;39(7):2190-3. doi: 10.1016/j.transproceed.2007.07.015. Transplant Proc. 2007. PMID: 17889134
[Prevention of cardiovascular risk in renal transplantation. Consensus document].
Morales JM, González Molina M, Campistol JM, del Castillo D, Anaya F, Oppenheimer F, Gil Vernet JM, Grinyo JM, Capdevila L, Lampreave I, Valdés F, Marcén R, Escuín F, Andrés A, Arias M, Pallardó L. Morales JM, et al. Among authors: capdevila l. Nefrologia. 2002;22 Suppl 4:35-56. Nefrologia. 2002. PMID: 12123140 Free article. Review. Spanish. No abstract available.
Tacrolimus is highly effective in both dual and triple therapy regimens following renal transplantation. Spanish and Italian Tacrolimus Study Group.
Segoloni G, Bonomini V, Maresca MC, Arisi L, Gonzalez-Molina M, Tarantino A, del Castillo D, Ortuño J, Carmellini M, Capdevila L, Arias M, Garcia J, Rigotti P. Segoloni G, et al. Among authors: capdevila l. Transpl Int. 2000;13 Suppl 1:S336-40. doi: 10.1007/s001470050356. Transpl Int. 2000. PMID: 11112027 Clinical Trial.
117 results